Bargain hunters are wise to pay careful attention to insider buying, because although there are many various reasons for an insider to sell a stock, presumably the only reason they would use their hard-earned dollars to make a purchase, is that they expect to make money.
Today we look at two noteworthy recent insider buys.
Bargain hunters are wise to pay careful attention to insider buying, because although there are many various reasons for an insider to sell a stock, presumably the only reason they would use their hard-earned dollars to make a purchase, is that they expect to make money.
Today we look at two noteworthy recent insider buys.
At Change Healthcare, a filing with the SEC revealed that on Wednesday, CFO Fredrik J.
Eliasson purchased 100,000 shares of CHNG, for a cost of $12.00 each, for a total investment of $1.2M.
Investors can snag CHNG even cheaper than Eliasson did, with the stock trading as low as $10.23 at last check today -- that's 14.7% under Eliasson's purchase price.
Change Healthcare Inc is trading up about 1% on the day Monday.
Before this latest buy, Eliasson purchased CHNG at 2 other times during the past twelve months, for a total investment of $939,200 at an average of $13.42 per share.
And on Thursday, CEO Douglas C.
Bryant purchased $801,670 worth of Quidel, purchasing 5,000 shares at a cost of $160.33 each.
Quidel is trading up about 10.4% on the day Monday.
Bryant was up about 19.3% on the buy at the high point of today's trading session, with QDEL trading as high as $191.23 in trading on Monday.